The Fifth Annual Cosmeceuticals conference in New York will pick out potential opportunities and pitfalls in the fast-growing market for complex beauty products.
Covering everything from promising technologies in anti-aging to legal quandaries, the two-day conference will kick-off on June 26 at the Marriot East Hotel.
Event organizers ALM are inviting established players and new-entrants alike to learn about the latest trends and challenges.
Speakers at the event include Lauran Thaman, the global director of Proctor & Gamble (P&G) Beauty Science, who will talk about scientific advances in skin and hair care.
Among the other sessions on the formulation side is a presentation on emerging uses of trace minerals and antioxidants in anti-aging products, given by Karen Burke from the Dermatology Department at the Mount Sinai Medical Center.
Marketing trends will also be on the conference menu with representatives of leading research companies including Kline & Company and Datamonitor sharing their insights with the attendees.
Natural ingredients and ethnic products will feature in the discussions on opportunities in the cosmeceuticals market.
For example, Andrew Alexis, the director of the Skin of Color Center at St. Luke's Roosevelt Hospital will discuss the formulation challenges, consumer needs and marketing concerns relevant to ethnic cosmeceuticals.
Legal and regulatory issues will also be high on the agenda.
Because cosmeceuticals straddle the boundary between cosmetics and drugs manufacturers can easily fall into legal traps.
An expert panel of lawyers including Thomas Cohen, senior attorney at the Federal Trade Commission, will discuss controversial claims, compliance strategies and regulatory priorities.
The impact of European regulations and how drug safety and efficacy rules apply to cosmeceuticals will also be covered at the conference.
Cosmeceuticals is a booming category in the US beauty market. A report from Packaging Facts published this month said US cosmeceutical sales are now worth $16bn and are expected to reach $21bn by 2012.